{"id":"NCT00599521","sponsor":"Galderma R&D","briefTitle":"Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%","officialTitle":"A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2008-11","completion":"2008-12","firstPosted":"2008-01-23","resultsPosted":"2011-04-19","lastUpdate":"2021-02-18"},"enrollment":1067,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"Adapalene lotion 0.1%","otherNames":[]},{"type":"DRUG","name":"Adapalene Lotion Vehicle","otherNames":[]}],"arms":[{"label":"Adapalene lotion 0.1%","type":"EXPERIMENTAL"},{"label":"Adapalene Lotion vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris.","primaryOutcome":{"measure":"Co-Primary Endpoint: Success Rate on Investigator's Global Assessment (IGA) From Baseline to Week 12","timeFrame":"From Baseline to Week 12","effectByArm":[{"arm":"Adapalene Lotion 0.1%","deltaMin":24.1,"sd":null},{"arm":"Adapalene Lotion Vehicle 0%","deltaMin":16.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":34,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":535},"commonTop":["Dry Skin"]}}